NCT02124239View on ClinicalTrials.gov

Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

79

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions

Actinic Keratosis

Interventions

DRUG

Ingenol mebutate

Trial Locations (1)

47106

Academic Dermatology Associate, Albuquerque

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY